Another UK authority looking into Novo Nordisk's marketing violation
The Medicines and Healthcare products Regulatory Agency will investigate ”whether regulatory action is also appropriate” after another UK authority took action against the Danish drugmaker.
by christian bundgaard, translated by daniel pedersen
The UK Medicines and Healthcare products Regulatory Agency (MHRA) is now starting an investigation into Novo Nordisk’s marketing violation case in the UK, reports industry media Endpoints News.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
.jpg)
UK pharma group suspends Novo Nordisk for two years
For subscribers
.jpg)
